Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10829462
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10829460
[6,6] fused bicyclic HDAC8 inhibitors
granted -
US 10822301
3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase
granted -
US 10822316
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10821178
Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
granted -
US 10822337
TGF-β inhibitorC
granted -
US 10815206
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 10813934
Sirtuin modulators as inhibitors of cytomegalovirus
granted -
US 10815239
Compounds useful as inhibitors of ATR kinase
granted -
US 10814010
FOXC2 inhibitor and methods of use thereof
granted -
US 10815271
Structure-based peptide inhibitors of alpha-synuclein aggregation
granted -
US 10813929
Treating cancer with ATR inhibitors
granted -
US 10808010
Peptide inhibitors of phosphoglycerate mutase and methods of use
granted -
US 10806794
Protease inhibitors having enhanced features
granted -
US 10806730
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10800774
Heterocyclic inhibitors of ATR kinase
granted -
US 10800781
Compounds useful as inhibitors of ATR kinase
granted -
US 10800782
Inhibitors of cellular metabolic processes
granted -
US 10800769
Heterocyclic inhibitors of ATR kinase
granted -
US 10793563
GCN2 inhibitors and uses thereof
granted -
US 10792282
Protein kinase C inhibitors and uses thereof
granted -
US 10793543
Selective C-KIT kinase inhibitor
granted -
US 10787490
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 10786495
Vesicular monoamine transporter 2 inhibitors for treating stuttering
granted